Cognios Capital’s Edwards Lifesciences EW Stock Holding History

Cognios Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-117	Closed	-$7K	–	82
2020 Q1	$7K	Buy	+117	New	+$8.44K	﹤0.01%	229
2018 Q4	–	Sell	-40,314	Closed	-$2.34M	–	143
2018 Q3	$2.34M	Sell	40,314 -12,015	-23%	-$588K	0.96%	21
2018 Q2	$2.54M	Sell	52,329 -381	-0.7%	-$17.8K	0.89%	38
2018 Q1	$2.45M	Sell	52,710 -2,796	-5%	-$121K	0.89%	36
2017 Q4	$2.08M	Buy	+55,506	New	+$2.04M	0.79%	64
2016 Q1	–	Sell	-16,278	Closed	-$428K	–	111
2015 Q4	$428K	Hold	16,278	–	–	0.22%	81
2015 Q3	$385K	Hold	16,278	–	–	0.22%	73
2015 Q2	$386K	Hold	16,278	–	–	0.22%	70
2015 Q1	$386K	Hold	16,278	–	–	0.23%	72
2014 Q4	$345K	Sell	16,278 -187,656	-92%	-$3.77M	0.24%	74
2014 Q3	$3.47M	Buy	+203,934	New	+$3.22M	2.44%	14

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Cognios Capital's EW Position: Q2 2020 in Review

Cognios Capital sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 117 shares — an estimated $7K sold.

Cognios Capital first reported a position in EW in Q3 2014 and held it in 11 quarters. The position peaked at $3.47M in Q3 2014. 1,048 funds tracked by Wall St. Rank hold EW as of Q2 2020.

Cognios Capital reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
Cognios Capital sold 117 Edwards Lifesciences shares in Q2 2020, an estimated $7K.
Cognios Capital first reported a position in Edwards Lifesciences in Q3 2014 and held it in 11 quarters.
Cognios Capital's Edwards Lifesciences position peaked at $3.47M in Q3 2014.
1,048 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Cognios Capital's 13F filing for Q2 2020.